Skip to main content
Premium Trial:

Request an Annual Quote

MOgene Becomes Certified Agilent Microarray Service Provider

NEW YORK, Oct. 4 (GenomeWeb News) - Agilent Technologies has certified MOgene to become an microarray service provider, the companies said today -- the second company in North America to receive this kind a certification, the companies said today.


The certification validates MOgene's "ability to provide ... microarray processing and data analysis services" using Agilent microarrays, the companies said.


MOgene launched its microarray services business in March, and has offered research services using Agilent custom and catalog microarrays to researchers at universities, biotechnology and pharmaceutical companies, and agrochemical companies. 


Agilent certifies companies "once laboratory personnel complete a training program and the laboratory, as a whole, passes a rigorous set of assessments," the companies said.


To be eligible, a service laboratory "must analyze Agilent 60-mer microarrays on the complete Agilent gene expression platform" -- which comprises a microarray scanner, hybridization and labeling kits, feature extraction software, and one of the Rosetta gene expression data analysis systems.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.